Title : System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.

Pub. Date : 2010

PMID : 20208386






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gemfibrozil and bupropion represent examples of glucuronidation-dependent and reduction-dependent activation to metabolites that inhibit CYP2C8 and CYP2D6, respectively, whereas ezetimibe represents an example of glucuronidation-dependent protection against metabolism-dependent inhibition of CYP3A4. Ezetimibe cytochrome P450 family 2 subfamily C member 8 Homo sapiens